BRISTOL-MYERS SQUIBB COMPANY Revenue, Net (Deprecated 2018-01-31)
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Revenue, Net (Deprecated 2018-01-31) of $5.69 billion for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-25.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2018-10-25
- BRISTOL-MYERS SQUIBB COMPANY revenue, net (deprecated 2018-01-31) for the quarter ending 2018-09-30 was $5.69B, a 8.32% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY revenue, net (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $5.70B, a 10.89% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $5.19B, a 5.36% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $5.45B, a 3.93% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY revenue, net (deprecated 2018-01-31) for fiscal 2017 was $20.78B, a 6.94% increase from fiscal 2016.
- BRISTOL-MYERS SQUIBB COMPANY revenue, net (deprecated 2018-01-31) for fiscal 2016 was $19.43B, a 17.31% increase from fiscal 2015.
- BRISTOL-MYERS SQUIBB COMPANY revenue, net (deprecated 2018-01-31) for fiscal 2015 was $16.56B, a 4.29% increase from fiscal 2014.
- BRISTOL-MYERS SQUIBB COMPANY revenue, net (deprecated 2018-01-31) for fiscal 2014 was $15.88B, a 3.09% decline from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 6 month as first filed | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 9 month as first filed | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|---|
| 2018-09-30 | $5.69B 10-Q · filed 2018-10-25 | $11.39B derived: sum of 2 quarters · filed 2018-10-25 | $16.59B 10-Q · filed 2018-10-25 | $22.04B derived: sum of 4 quarters · filed 2018-10-25 | |||
| 2018-06-30 | $5.70B 10-Q · filed 2018-07-26 | $10.90B 10-Q · filed 2018-07-26 | $16.35B derived: sum of 3 quarters · filed 2018-07-26 | $21.60B derived: sum of 4 quarters · filed 2018-10-25 | |||
| 2018-03-31 | $5.19B 10-Q · filed 2018-04-26 | $10.64B derived: sum of 2 quarters · filed 2018-04-26 | $15.90B derived: sum of 3 quarters · filed 2018-10-25 | $21.04B derived: sum of 4 quarters · filed 2018-10-25 | |||
| 2017-12-31 | $5.45B 10-K · filed 2018-02-13 | $10.70B derived: sum of 2 quarters · filed 2018-10-25 | $15.85B derived: sum of 3 quarters · filed 2018-10-25 | $20.78B 10-K · filed 2018-02-13 | |||
| 2017-09-30 | $5.25B 10-Q · filed 2018-10-25 | $10.40B derived: sum of 2 quarters · filed 2018-10-25 | $15.33B 10-Q · filed 2018-10-25 | $20.57B derived: sum of 4 quarters · filed 2018-10-25 | |||
| 2017-06-30 | $5.14B 10-Q · filed 2018-07-26 | $10.07B 10-Q · filed 2018-07-26 | $15.32B derived: sum of 3 quarters · filed 2018-07-26 | $20.24B derived: sum of 4 quarters · filed 2018-07-26 | |||
| 2017-03-31 | $4.93B 10-Q · filed 2018-04-26 | $10.17B derived: sum of 2 quarters · filed 2018-04-26 | $15.09B derived: sum of 3 quarters · filed 2018-04-26 | $19.96B derived: sum of 4 quarters · filed 2018-04-26 | |||
| 2016-12-31 | $5.24B 10-K · filed 2018-02-13 | $10.16B derived: sum of 2 quarters · filed 2018-02-13 | $15.04B derived: sum of 3 quarters · filed 2018-02-13 | $19.43B 10-K · filed 2018-02-13 | |||
| 2016-09-30 | $4.92B 10-K · filed 2018-02-13 | $9.79B derived: sum of 2 quarters · filed 2018-02-13 | $14.18B 10-Q · filed 2017-10-26 | $18.47B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-06-30 | $4.87B 10-K · filed 2018-02-13 | $9.26B 10-Q · filed 2017-07-27 | $13.55B derived: sum of 3 quarters · filed 2018-02-13 | $17.62B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-03-31 | $4.39B 10-K · filed 2018-02-13 | $8.68B derived: sum of 2 quarters · filed 2018-02-13 | $12.75B derived: sum of 3 quarters · filed 2018-02-13 | $16.91B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2015-12-31 | $4.29B 10-K · filed 2017-02-21 | $8.36B derived: sum of 2 quarters · filed 2017-02-21 | $12.52B derived: sum of 3 quarters · filed 2017-02-21 | $16.56B 10-K · filed 2018-02-13 | |||
| 2015-09-30 | $4.07B 10-K · filed 2017-02-21 | $8.23B derived: sum of 2 quarters · filed 2017-02-21 | $12.27B 10-Q · filed 2016-10-27 | $16.53B derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-06-30 | $4.16B 10-K · filed 2017-02-21 | $8.20B 10-Q · filed 2016-07-28 | $12.46B derived: sum of 3 quarters · filed 2017-02-21 | $16.38B derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-03-31 | $4.04B 10-K · filed 2017-02-21 | $8.30B derived: sum of 2 quarters · filed 2017-02-21 | $12.22B derived: sum of 3 quarters · filed 2017-02-21 | $16.11B derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2014-12-31 | $4.26B 10-K · filed 2016-02-12 | $8.18B derived: sum of 2 quarters · filed 2016-02-12 | $12.07B derived: sum of 3 quarters · filed 2016-02-12 | $15.88B 10-K · filed 2017-02-21 | |||
| 2014-09-30 | $3.92B 10-K · filed 2016-02-12 | $7.81B derived: sum of 2 quarters · filed 2016-02-12 | $11.62B 10-Q · filed 2015-10-27 | $16.06B derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-06-30 | $3.89B 10-K · filed 2016-02-12 | $7.70B 10-Q · filed 2015-07-23 | $12.14B derived: sum of 3 quarters · filed 2016-02-12 | $16.21B derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-03-31 | $3.81B 10-K · filed 2016-02-12 | $8.25B derived: sum of 2 quarters · filed 2016-02-12 | $12.32B derived: sum of 3 quarters · filed 2016-02-12 | $16.36B derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2013-12-31 | $4.44B 10-K · filed 2015-02-13 | $8.51B derived: sum of 2 quarters · filed 2015-02-13 | $12.55B derived: sum of 3 quarters · filed 2015-02-13 | $16.39B 10-K · filed 2016-02-12 | |||
| 2013-09-30 | $4.07B 10-K · filed 2015-02-13 | $8.11B derived: sum of 2 quarters · filed 2015-02-13 | $11.94B 10-Q · filed 2014-10-24 | $16.14B derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-06-30 | $4.05B 10-K · filed 2015-02-13 | $7.88B 10-Q · filed 2014-07-24 | $12.07B derived: sum of 3 quarters · filed 2015-02-13 | $15.81B derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-03-31 | $3.83B 10-K · filed 2015-02-13 | $8.02B derived: sum of 2 quarters · filed 2015-02-13 | $11.76B derived: sum of 3 quarters · filed 2015-02-13 | $16.20B derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2012-12-31 | $4.19B 10-K · filed 2014-02-14 | $7.93B derived: sum of 2 quarters · filed 2014-02-14 | $12.37B derived: sum of 3 quarters · filed 2014-02-14 | $17.62B 10-K · filed 2015-02-13 | |||
| 2012-09-30 | $3.74B 10-K · filed 2014-02-14 | $8.18B derived: sum of 2 quarters · filed 2014-02-14 | $13.43B 10-Q · filed 2013-10-23 | $18.88B derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2012-06-30 | $4.44B 10-K · filed 2014-02-14 | $9.69B 10-Q · filed 2013-07-25 | $15.15B derived: sum of 3 quarters · filed 2014-02-14 | $20.49B derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2012-03-31 | $5.25B 10-K · filed 2014-02-14 | $10.71B derived: sum of 2 quarters · filed 2014-02-14 | $16.05B derived: sum of 3 quarters · filed 2014-02-14 | $21.48B derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2011-12-31 | $5.45B 10-K · filed 2013-02-15 | $10.80B derived: sum of 2 quarters · filed 2013-02-15 | $16.23B derived: sum of 3 quarters · filed 2013-02-15 | $21.24B 10-K · filed 2014-02-14 | |||
| 2011-09-30 | $5.34B 10-K · filed 2013-02-15 | $10.78B derived: sum of 2 quarters · filed 2013-02-15 | $15.79B 10-Q · filed 2012-10-24 | $20.90B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-06-30 | $5.43B 10-K · filed 2013-02-15 | $10.45B 10-Q · filed 2012-07-25 | $15.56B derived: sum of 3 quarters · filed 2013-02-15 | $20.35B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-03-31 | $5.01B 10-K · filed 2013-02-15 | $10.12B derived: sum of 2 quarters · filed 2013-02-15 | $14.92B derived: sum of 3 quarters · filed 2013-02-15 | $19.69B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2010-12-31 | $5.11B 10-K · filed 2012-02-17 | $9.91B derived: sum of 2 quarters · filed 2012-02-17 | $14.68B derived: sum of 3 quarters · filed 2012-02-17 | $19.48B 10-K · filed 2013-02-15 | |||
| 2010-09-30 | $4.80B 10-K · filed 2012-02-17 | $9.57B derived: sum of 2 quarters · filed 2012-02-17 | $14.37B 10-Q · filed 2011-10-27 | $19.41B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-06-30 | $4.77B 10-K · filed 2012-02-17 | $9.57B 10-Q · filed 2011-07-28 | $14.61B derived: sum of 3 quarters · filed 2012-02-17 | $19.40B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-03-31 | $4.81B 10-K · filed 2012-02-17 | $9.84B derived: sum of 2 quarters · filed 2012-02-17 | $14.63B derived: sum of 3 quarters · filed 2012-02-17 | $19.29B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2009-12-31 | $5.03B 10-K · filed 2011-02-18 | $9.82B derived: sum of 2 quarters · filed 2011-02-18 | $14.49B derived: sum of 3 quarters · filed 2011-02-18 | $18.81B 10-K · filed 2012-02-17 | |||
| 2009-09-30 | $4.79B 10-K · filed 2011-02-18 | $5.49B 10-Q · filed 2009-10-22 | $9.45B derived: sum of 2 quarters · filed 2011-02-18 | $13.78B 10-Q · filed 2010-10-26 | $15.89B 10-Q · filed 2009-10-22 | $16.14B derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-06-30 | $4.67B 10-K · filed 2011-02-18 | $5.38B 10-Q · filed 2009-07-23 | $8.99B 10-Q · filed 2010-07-22 | $10.40B 10-Q · filed 2009-07-23 | $11.35B derived: sum of 3 quarters · filed 2011-02-18 | $16.61B derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-03-31 | $4.32B 10-K · filed 2011-02-18 | $6.69B derived: sum of 2 quarters · filed 2011-02-18 | $11.94B derived: sum of 3 quarters · filed 2011-02-18 | $17.15B derived: sum of 4 quarters · filed 2011-02-18 | |||
| 2008-12-31 | $2.37B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $7.62B derived: sum of 2 quarters · filed 2011-02-18 | $12.82B derived: sum of 3 quarters · filed 2011-02-18 | $17.71B 10-K · filed 2011-02-18 | |||
| 2008-09-30 | $5.25B 10-Q · filed 2009-10-22 | $10.46B derived: sum of 2 quarters · filed 2009-10-22 | $15.35B 10-Q · filed 2009-10-22 | ||||
| 2008-06-30 | $5.20B 10-Q · filed 2009-07-23 | $10.09B 10-Q · filed 2009-07-23 | |||||
| 2007-12-31 | $15.62B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |